MedPath

The study on the effect of chammomile&lemon balm syrupe in cardiac syndrome x

Phase 3
Conditions
cardiac syndrome x.
Angina pectoris, unspecified
I20.9
Registration Number
IRCT20180608040014N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Angina- like chest pain
positive exercise stress test
angiographically normal epicardial coronary arteries
no response to treatments in conventional medicine
4.Recurrent chest pain despite conventional treatment at least 6 months, including a combination of two anti-ischemic (beta-blockers, calcium antagonists) or one anti-ischemic and one alternative( nitrate Statin, ACEI)

Exclusion Criteria

sever Valvular heart disease
cardiomyopathy
coronary spasm
LV dysfunction
uncontrolled Diabetes mellitus
uncontrolled HTN
History of myocardial infarction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The overall score of pain in the Seattle Angina Questionnaire. Timepoint: at first and end of study(45 days and 90 days after inclusion in the study). Method of measurement: the Seattle Angina questionnare.
Secondary Outcome Measures
NameTimeMethod
Quality of Life Score in SF36 Quality of Life Questionnaire. Timepoint: at enrolling in the study and 45 days and 90 days after enrolling in the study. Method of measurement: SF36 Quality of Life Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath